News

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission ...
I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.
A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...
The European Commission has granted marketing authorization in the European Union (EU) for German pharma major Bayer’s Nubeqa ...
Hot flashes are often viewed as a women’s health issue particularly during menopause However men can experience it too and due to various reasons Here’s everything you need to know about hot flashes i ...
EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...
Berlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa ...
Artificial intelligence (AI) is transforming healthcare across multiple fields, and prostate cancer (PCa)  is no exception. A ...
European Union approves Bayer’s Nubeq for patients with advanced prostate cancer: Berlin Tuesday, July 22, 2025, 11:00 Hrs [IST] The European Commission has granted marketing au ...
Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate ...